Stock Update (NASDAQ:GILD): Gilead Announces Promotion of Katie Watson to Executive Vice President, Human Resources

[Business Wire] – Gilead Sciences, Inc. today announced the promotion of Katie Watson to Executive Vice President, Human Resources. Read more on this. Gilead Sciences Inc. (GILD) , with a current market cap of $121.13B, opened at $82.32. During the trading session, GILD traded between $82.28 to $84.52 with its 52-week range being $82.28 to $123.37. GILD shares are currently priced at 6.80x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s -3.62x forward p/e ratio. The company pays shareholders $1.72 per share in dividend income per year, for a current yield of 2.07%. According to a consensus of 19 analysts, the earnings estimate of $2.99 per share would be $0.56 better than the year-ago quarter and a $0.03 sequential increase. The full-year EPS estimate is $12.21 which would be a $4.12 improvement than last year’s full-year earnings. The quarterly earnings estimate is predicated on a consensus revenue forecast of $8.12 Billion. If reported, that would be a 11.08% increase over the year-ago quarter. Recently, Credit Suisse Initiated GILD at Outperform (Jan 20, 2016). Previously, BofA/Merrill upgraded GILD from Underperform to Neutral. Investors should keep in mind is that the average price target is $123.24, which is 49.71% above where the stock opened this morning. See more in (NASDAQ:GILD) Similar Articles: Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF) for the Treatment of Chronic Hepatitis B Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences Announces Fourth Quarter 2015 Dividend Stock Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Provides Update on Investigational Compound, GS-5734, for the Treatment of Ebola Virus Disease